Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local mitomycin C application for stricturing Crohn's disease
2008-002246-33Phase 3Active
- Sponsor
- Luigi Sacco University Hospital
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of mitomycin c in Crohn's disease and gastrointestinal conditions (2 arms), sponsored by Luigi Sacco University Hospital. Primary endpoints: Avoidance of endoscopic or surgical treatment at 3 months and Avoidance of endoscopic or surgical treatment at 12 months. Started May 2008; status: active.
02
Drugs
mitomycin c
03
Conditions
Crohn's diseasegastrointestinal conditions
Beyond the preview
Go deeper on 2008-002246-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002246-33.